Business ❯Pharmaceutical Industry

Drug Market

Obesity Drugs Weight Loss Drugs Supply Chain Management Regulatory Environment Central Nervous System Treatments Semaglutide Shortage Weight Loss Medications Obesity Treatments Pricing Strategies FDA Regulations

Pfizer Halts Development of Oral Weight-Loss Pill After Liver Injury

The decision follows a trial participant's liver injury and reflects ongoing safety challenges in the competitive obesity drug market.

Shionogi's COVID Pill Shows Promise in Reducing Transmission

Bristol Myers Squibb Acquires Karuna Therapeutics in $14 Billion Deal